https://www.ajmc.com/view/patients-with-rrmm-are-undertreated-with-carfilzomib-in-the-real-world-study-finds
Since carfilzomib was approved at a 27 mg/m2 twice-weekly dose, it has since been optimized at 56 mg/m2 twice-weekly and a recent study found benefits of a 70...
in thepatientsrrmmcarfilzomibreal